+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Therapeutic Drug Monitoring Market Analysis, By Product Type (Consumables, Equipment ) By Technology Type (Immunoassays, and Others) By Drug Type, By End Use (Hospital Laboratories, Commercial/Private Laboratories, And Others), Forecasts To 2026

  • ID: 5351590
  • Report
  • November 2019
  • Region: Global
  • 150 pages
  • Reports and Data
Increasing prevalence of infectious diseases and need for therapeutic drug monitoring are key factors driving market revenue growth.

Market Size - USD 1,453.7 Million in 2020, Market Growth - CAGR of 6.6%, Market Trends - Increasing funding for research and favorable regulatory scenario by government of various countries.

The global therapeutic drug monitoring market size is expected to reach USD 2,429.1 Million in 2028, and register a CAGR of 6.6% during the forecast period. Increasing organ transplantation incidences resulting in high adoption of therapeutic drug monitoring technique, rising investments from government and private companies for research funding, strategic planning by major players such as mergers and acquisitions, partnerships, agreements, etc.

Therapeutic Drug Monitoring (TDM) is a branch of clinical pharmacology and chemistry, which measures and maintains specific drug concentration levels in body fluids or blood streams. The monitoring process is aimed at refining patient care for better outcomes by adjusting the drug dosage.

Some Key Findings From the Report:
  • Among the product type segments, the equipment segment accounted for the largest revenue share of 54.6% in 2020.
  • Among the end use segments, the hospital laboratories segment accounted for major revenue share in 2020, owing to large number of patient footfalls in hospitals.
  • North America market accounted for the largest revenue share in the global market in 2020, and is expected to continue with its dominance over the forecast period, due to presence of major players operating in countries in the region.
  • The Asia Pacific market size was USD 334.4 Million in 2020. Revenue from the Asia Pacific market is expected to expand at a robust growth rate during the forecast period.
  • Key players profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche AG (Roche Diagnostics), Bio-Rad Laboratories Inc., Beckman Coulter, Inc., Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, Alpco, and Randox Laboratories Ltd. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global therapeutic drug monitoring market is segmented on the basis of product type, technology type, drug type, end use, and region:

Product Type
  • Consumables
  • Equipment
Technology Type
  • Immunoassays
  • Colorimetric Immunoassays
  • Radioimmunoassays
  • Other Immunoassays
  • Chromatography-MS
Class of Drug Type
  • Antiepileptic Drugs
  • Antiarrhythmic Drugs
  • Immunosuppressant Drugs
  • Antibiotic Drugs
  • Bronchodilator Drugs
  • Psychoactive Drugs
  • Other Drug Classes
End Use
  • Hospital Laboratories
  • Commercial/Private Laboratories
  • Other End Users
Region Outlook
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa
Reasons to Buy the Report
  • A robust analysis and estimation of the Therapeutic Drug Monitoring Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
  • A holistic competitive landscape of the all the major players in the Therapeutic Drug Monitoring Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Note: Product cover images may vary from those shown
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 2026

Chapter 3. Indicative Metrics
3.1. Increasing incidences of chronic and infectious diseases
3.2. Use in Monitoring of Biosimilars in Autoimmune Diseases
3.3. Technological advancements
3.4. Operational Barriers Faced while Conducting TDM Tests

Chapter 4. Therapeutic Drug Monitoring Segmentation & Impact Analysis
4.1. Therapeutic Drug Monitoring Segmentation Analysis
4.2. Therapeutic Drug Monitoring Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Therapeutic Drug Monitoring Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. Use in traditional anticancer therapies
4.4.1.2. Rising Number of Organ Transplant Procedures
4.4.2. Market restraint analysis
4.4.2.1. Reluctance in offering TDM service by small hospitals
4.5. Key opportunities prioritized
4.6. Therapeutic Drug Monitoring Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Therapeutic Drug Monitoring PESTEL Analysis

Chapter 5. Therapeutic Drug Monitoring Market By Product Type Insights & Trends
5.1. Therapeutic Drug Monitoring Product Type dynamics & Market Share, 2018 & 2026
5.2. Consumables
5.2.1. Market estimates and forecast, 2016 2026 (USD Million)
5.2.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
5.3. Equipment
5.3.1. Market estimates and forecast, 2016 2026 (USD Million)
5.3.2. Market estimates and forecast, by region, 2016 2026 (USD Million)

Chapter 6. Therapeutic Drug Monitoring Market By Technology Type Insights & Trends
6.1. Therapeutic Drug Monitoring Technology Type dynamics & Market Share, 2018 & 2026
6.2. Immunoassays
6.2.1. Market estimates and forecast, 2016 2026 (USD Million)
6.2.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.3. Colorimetric Immunoassays
6.3.1. Market estimates and forecast, 2016 2026 (USD Million)
6.3.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.4. Radioimmunoassays
6.4.1. Market estimates and forecast, 2016 2026 (USD Million)
6.4.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.5. Other Immunoassays
6.5.1. Market estimates and forecast, 2016 2026 (USD Million)
6.5.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
6.6. Chromatography-MS
6.6.1. Market estimates and forecast, 2016 2026 (USD Million)
6.6.2. Market estimates and forecast, by region, 2016 2026 (USD Million)

Chapter 7. Therapeutic Drug Monitoring Market By Class of Drug Type Insights & Trends
7.1. Therapeutic Drug Monitoring Class of Drug Type dynamics & Market Share, 2018 & 2026
7.2. Antiepileptic Drugs
7.2.1. Market estimates and forecast, 2016 2026 (USD Million)
7.2.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
7.3. Antiarrhythmic Drugs
7.3.1. Market estimates and forecast, 2016 2026 (USD Million)
7.3.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
7.4. Immunosuppressant Drugs
7.4.1. Market estimates and forecast, 2016 2026 (USD Million)
7.4.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
7.5. Antibiotic Drugs
7.5.1. Market estimates and forecast, 2016 2026 (USD Million)
7.5.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
7.6. Bronchodilator Drugs
7.6.1. Market estimates and forecast, 2016 2026 (USD Million)
7.6.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
7.7. Psychoactive Drugs
7.7.1. Market estimates and forecast, 2016 2026 (USD Million)
7.7.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
7.8. Others
7.8.1. Market estimates and forecast, 2016 2026 (USD Million)
7.8.2. Market estimates and forecast, by region, 2016 2026 (USD Million)

Chapter 8. Therapeutic Drug Monitoring Market By End Use Insights & Trends
8.1. Therapeutic Drug Monitoring End Use dynamics & Market Share, 2018 & 2026
8.2. Hospital Laboratories
8.2.1. Market estimates and forecast, 2016 2026 (USD Million)
8.2.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
8.3. Commercial/Private Laboratories
8.3.1. Market estimates and forecast, 2016 2026 (USD Million)
8.3.2. Market estimates and forecast, by region, 2016 2026 (USD Million)
8.4. Others
8.4.1. Market estimates and forecast, 2016 2026 (USD Million)
8.4.2. Market estimates and forecast, by region, 2016 2026 (USD Million)

Chapter 9. Therapeutic Drug Monitoring Market Regional Outlook
9.1. Therapeutic Drug Monitoring Market share by region, 2018 & 2026
9.2. North America
9.2.1. North America Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.2.2. North America Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.2.3. North America Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.2.4. North America Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.2.5. North America Therapeutic Drug Monitoring Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.2.6. U.S.
9.2.6.1. U.S. Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.2.6.2. U.S. Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.2.6.3. U.S. Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.2.6.4. U.S. Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.2.6.5. U.S. Therapeutic Drug Monitoring Market estimates and forecast by End use, 2016 2026, (USD Million)
9.2.7. Canada
9.2.7.1. Canada Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.2.7.2. Canada Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.2.7.3. Canada Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.2.7.4. Canada Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.2.7.5. Canada Therapeutic Drug Monitoring Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.2.8. Mexico
9.2.8.1. Mexico Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.2.8.2. Mexico Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.2.8.3. Mexico Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.2.8.4. Mexico Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.2.8.5. Mexico Therapeutic Drug Monitoring Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3. Europe
9.3.1. Europe Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.3.2. Europe Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.3.3. Europe Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.4. Europe Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.3.5. Europe Therapeutic Drug Monitoring Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.6. Germany
9.3.6.1. Germany Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.3.6.2. Germany Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.3.6.3. Germany Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.6.4. Germany Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.3.6.5. Germany Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.7. France
9.3.7.1. France Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.3.7.2. France Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.3.7.3. France Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.7.4. France Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.3.7.5. France Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.8. U.K.
9.3.8.1. U.K Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.3.8.2. U.K Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.3.8.3. U.K. Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.8.4. U.K. Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.3.8.5. U.K. Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.9. Spain
9.3.9.1. Spain Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.3.9.2. Spain Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.3.9.3. Spain. Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.9.4. Spain Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.3.9.5. Spain Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.10. Italy
9.3.10.1. Italy Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.3.10.2. Italy Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.3.10.3. Italy Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.10.4. Italy Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.3.10.5. Italy Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.3.11. Rest of Europe
9.3.11.1. Rest of Europe Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.3.11.2. Rest of Europe Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.3.11.3. Rest of Europe Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.3.11.4. Rest of Europe Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.3.11.5. Rest of Europe Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.4.2. Asia Pacific Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.4.3. Asia Pacific Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.4. Asia Pacific Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.4.5. Asia Pacific Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4.6. China
9.4.6.1. China Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.4.6.2. China Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.4.6.3. China Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.6.4. China Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.4.6.5. China Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4.7. Japan
9.4.7.1. Japan Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.4.7.2. Japan Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.4.7.3. Japan Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.7.4. Japan Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.4.7.5. Japan Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4.8. India
9.4.8.1. India Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.4.8.2. India Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.4.8.3. India Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.8.4. India Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.4.8.5. India Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4.9. Australia
9.4.9.1. Australia Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.4.9.2. Australia Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.4.9.3. Australia Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.9.4. Australia Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.4.9.5. Australia Therapeutic Drug Monitoring Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4.10. South Korea
9.4.10.1. South Korea Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.4.10.2. South Korea Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.4.10.3. South Korea Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.10.4. South Korea Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.4.10.5. South Korea Therapeutic Drug Monitoring Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.4.11. Rest of Asia Pacific
9.4.11.1. Rest of Asia Pacific Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.4.11.2. Rest of Asia Pacific Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.4.11.3. Rest of Asia Pacific Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.4.11.4. Rest of Asia Pacific Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.4.11.5. Rest of Asia Pacific Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.5. Middle East & Africa
9.5.1. Middle East and Africa Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.5.2. Middle East and Africa Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.5.3. Middle East and Africa Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.5.4. Middle East and Africa Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.5.5. Middle East and Africa Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.5.6. South Africa
9.5.6.1. South Africa Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.5.6.2. South Africa Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.5.6.3. South Africa Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.5.6.4. South Africa Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.5.6.5. South Africa Therapeutic Drug Monitoring Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.5.7. Rest of Middle East and Africa
9.5.7.1. Rest of Middle East and Africa Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.5.7.2. Rest of Middle East and Africa Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.5.7.3. Rest of Middle East and Africa Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.5.7.4. Rest of Middle East and Africa Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.5.7.5. Rest of Middle East and Africa Therapeutic Drug Monitoring Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.6. Latin America
9.6.1. Latin America Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.6.2. Latin America Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.6.3. Latin America Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.6.4. Latin America Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.6.5. Latin America Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.6.6. Brazil
9.6.6.1. Brazil Therapeutic Drug Monitoring market estimates and forecast, 2016 2026, (USD Million)
9.6.6.2. Brazil Therapeutic Drug Monitoring market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.6.6.3. Brazil Therapeutic Drug Monitoring market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.6.6.4. Brazil Therapeutic Drug Monitoring market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.6.6.5. Brazil Therapeutic Drug Monitoring market estimates and forecast by End Use, 2016 2026, (USD Million)
9.6.7. Argentina
9.6.7.1. Argentina Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.6.7.2. Argentina Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.6.7.3. Argentina Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.6.7.4. Argentina Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.6.7.5. Argentina Therapeutic Drug Monitoring Market estimates and forecast by End Use, 2016 2026, (USD Million)
9.6.8. Rest of Latin America
9.6.8.1. Rest of Latin America Therapeutic Drug Monitoring Market estimates and forecast, 2016 2026, (USD Million)
9.6.8.2. Rest of Latin America Therapeutic Drug Monitoring Market estimates and forecast by Product Type, 2016 2026, (USD Million)
9.6.8.3. Rest of Latin America Therapeutic Drug Monitoring Market estimates and forecast by Technology Type, 2016 2026, (USD Million)
9.6.8.4. Rest of Latin America Therapeutic Drug Monitoring Market estimates and forecast by Class of Drug Type, 2016 2026, (USD Million)
9.6.8.5. Rest of Latin America Therapeutic Drug Monitoring Market estimates and forecast by End Use, 2016 2026, (USD Million)

Chapter 10. Competitive Landscape
10.1. Market Revenue Share by Manufacturers
10.2. Manufacturing Cost Breakdown Analysis
10.3. Mergers & Acquisitions
10.4. Strategy Benchmarking
10.5. Vendor Landscape

Chapter 11. Company Profiles
11.1. Abbott
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Length Benchmarking
11.1.4. Strategic Initiatives
11.2. F. Hoffmann-La Roche
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Length Benchmarking
11.2.4. Strategic Initiatives
11.3. Bio-Rad Laboratories Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Length Benchmarking
11.3.4. Strategic Initiatives
11.4. Beckman Coulter, Inc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Length Benchmarking
11.4.4. Strategic Initiatives
11.5. Roche Diagnostics
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Length Benchmarking
11.5.4. Strategic Initiatives
11.6. Siemens Healthineers
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Length Benchmarking
11.6.4. Strategic Initiatives
11.7. Thermo Fisher Scientific
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Length Benchmarking
11.7.4. Strategic Initiatives
11.8. Danaher Corporation
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Length Benchmarking
11.8.4. Strategic Initiatives
11.9. Alpco
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Length Benchmarking
11.9.4. Strategic Initiatives
11.10. Randox Laboratories Ltd.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Length Benchmarking
11.10.4. Strategic Initiatives
Note: Product cover images may vary from those shown
Adroll
adroll